Breaking News

AGC Biologics Supports Altheia Science’s Gene Therapy Programs

Milan facility provides lentiviral vector and autologous CD34+ cell-based drug products for clinical testing.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), entered a new partnership with Altheia Science, a gene therapy company pioneering cell and gene therapy strategies to treat autoimmune diseases and cancer. Under the alliance, Altheia Science aims to advance development of autoimmunity treatments, focused on modulating PD-L1 expression in patients’ hematopoietic stem and progenitor cells, into clinical testing.    AGC Biologics is performing d...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters